Stock listing
KRX:086820 Bio Solution Co., Ltd. (바이오솔루션) 주가
Follow Bio Solution Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:086820
₩4,610.00 KRW +105.00 (+2.3%)
Close on Nov 20, 2026
- Day range
- ₩4,485.00 – ₩4,695.00 KRWNov 20, 2026
- Volume
- 24,586 sharesNov 20, 2026
- Market cap
- ₩119.0B KRWAt the close on Nov 20, 2026 · price × 25.80M shares outstanding
- 52-week range
- ₩4,400.00 – ₩13,450.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩348.5M KRWMedian day 48,420 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:086820 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩4,610.00 | +105.00 | +2.3% | ₩4,695.00 | ₩4,695.00 | ₩4,485.00 | 24,586 | |
| ₩4,505.00 | -20.00 | -0.4% | ₩4,600.00 | ₩4,700.00 | ₩4,435.00 | 14,569 | |
| ₩4,525.00 | 0.00 | 0.0% | ₩4,620.00 | ₩4,620.00 | ₩4,400.00 | 17,940 | |
| ₩4,525.00 | -310.00 | -6.4% | ₩4,960.00 | ₩4,980.00 | ₩4,485.00 | 37,580 | |
| ₩4,835.00 | +135.00 | +2.9% | ₩4,700.00 | ₩4,970.00 | ₩4,665.00 | 83,031 | |
| ₩4,700.00 | -130.00 | -2.7% | ₩4,785.00 | ₩4,900.00 | ₩4,550.00 | 45,660 | |
| ₩4,830.00 | +60.00 | +1.3% | ₩4,850.00 | ₩4,900.00 | ₩4,625.00 | 49,166 | |
| ₩4,770.00 | +235.00 | +5.2% | ₩4,535.00 | ₩4,775.00 | ₩4,535.00 | 56,204 | |
| ₩4,535.00 | -115.00 | -2.5% | ₩4,635.00 | ₩4,675.00 | ₩4,430.00 | 36,056 | |
| ₩4,650.00 | -185.00 | -3.8% | ₩4,835.00 | ₩4,835.00 | ₩4,420.00 | 46,770 | |
| ₩4,835.00 | -215.00 | -4.3% | ₩4,970.00 | ₩5,110.00 | ₩4,715.00 | 30,158 | |
| ₩5,050.00 | +90.00 | +1.8% | ₩5,040.00 | ₩5,080.00 | ₩4,530.00 | 109,795 | |
| ₩4,960.00 | -290.00 | -5.5% | ₩5,250.00 | ₩5,390.00 | ₩4,920.00 | 85,857 | |
| ₩5,250.00 | -120.00 | -2.2% | ₩5,490.00 | ₩5,490.00 | ₩5,210.00 | 27,509 | |
| ₩5,370.00 | -90.00 | -1.6% | ₩5,410.00 | ₩5,550.00 | ₩5,285.00 | 33,581 | |
| ₩5,460.00 | -130.00 | -2.3% | ₩5,630.00 | ₩5,630.00 | ₩5,290.00 | 57,469 | |
| ₩5,590.00 | -60.00 | -1.1% | ₩5,640.00 | ₩5,690.00 | ₩5,460.00 | 57,043 | |
| ₩5,650.00 | +60.00 | +1.1% | ₩5,660.00 | ₩5,780.00 | ₩5,550.00 | 31,475 | |
| ₩5,590.00 | -130.00 | -2.3% | ₩5,720.00 | ₩5,830.00 | ₩5,490.00 | 31,337 | |
| ₩5,720.00 | -10.00 | -0.2% | ₩5,730.00 | ₩5,730.00 | ₩5,480.00 | 27,158 | |
| ₩5,730.00 | -160.00 | -2.7% | ₩5,870.00 | ₩5,990.00 | ₩5,630.00 | 37,458 | |
| ₩5,890.00 | -30.00 | -0.5% | ₩6,020.00 | ₩6,070.00 | ₩5,610.00 | 33,086 | |
| ₩5,920.00 | -20.00 | -0.3% | ₩5,900.00 | ₩6,100.00 | ₩5,740.00 | 29,376 | |
| ₩5,940.00 | -70.00 | -1.2% | ₩5,940.00 | ₩6,000.00 | ₩5,770.00 | 24,123 | |
| ₩6,010.00 | +90.00 | +1.5% | ₩5,920.00 | ₩6,100.00 | ₩5,700.00 | 44,556 | |
| ₩5,920.00 | -200.00 | -3.3% | ₩6,120.00 | ₩6,120.00 | ₩5,600.00 | 31,230 | |
| ₩6,120.00 | +330.00 | +5.7% | ₩5,800.00 | ₩6,340.00 | ₩5,800.00 | 57,638 | |
| ₩5,790.00 | -80.00 | -1.4% | ₩5,870.00 | ₩5,880.00 | ₩5,550.00 | 62,339 | |
| ₩5,870.00 | -720.00 | -10.9% | ₩6,520.00 | ₩6,520.00 | ₩5,830.00 | 222,130 | |
| ₩6,590.00 | -170.00 | -2.5% | ₩6,820.00 | ₩6,820.00 | ₩6,410.00 | 85,460 | |
| ₩6,760.00 | -10.00 | -0.1% | ₩6,860.00 | ₩6,860.00 | ₩6,680.00 | 23,542 | |
| ₩6,770.00 | +70.00 | +1.0% | ₩6,710.00 | ₩6,840.00 | ₩6,470.00 | 114,607 | |
| ₩6,700.00 | -190.00 | -2.8% | ₩6,900.00 | ₩6,990.00 | ₩6,560.00 | 64,130 | |
| ₩6,890.00 | +140.00 | +2.1% | ₩6,750.00 | ₩6,890.00 | ₩6,500.00 | 37,466 | |
| ₩6,750.00 | +160.00 | +2.4% | ₩6,500.00 | ₩6,910.00 | ₩6,410.00 | 60,581 | |
| ₩6,590.00 | -200.00 | -2.9% | ₩6,790.00 | ₩6,800.00 | ₩6,430.00 | 52,292 | |
| ₩6,790.00 | +400.00 | +6.3% | ₩6,340.00 | ₩6,970.00 | ₩6,270.00 | 145,136 | |
| ₩6,390.00 | -60.00 | -0.9% | ₩6,460.00 | ₩6,460.00 | ₩6,210.00 | 56,101 | |
| ₩6,450.00 | +100.00 | +1.6% | ₩6,380.00 | ₩6,790.00 | ₩6,290.00 | 80,605 | |
| ₩6,350.00 | -120.00 | -1.9% | ₩6,470.00 | ₩6,610.00 | ₩6,240.00 | 30,569 | |
| ₩6,470.00 | 0.00 | 0.0% | ₩6,440.00 | ₩6,560.00 | ₩6,300.00 | 55,152 | |
| ₩6,470.00 | -130.00 | -2.0% | ₩6,600.00 | ₩6,720.00 | ₩6,310.00 | 35,332 | |
| ₩6,600.00 | +150.00 | +2.3% | ₩6,610.00 | ₩6,610.00 | ₩6,400.00 | 52,323 | |
| ₩6,450.00 | +50.00 | +0.8% | ₩6,400.00 | ₩6,580.00 | ₩6,300.00 | 45,188 | |
| ₩6,400.00 | -170.00 | -2.6% | ₩6,500.00 | ₩6,680.00 | ₩6,300.00 | 18,758 | |
| ₩6,570.00 | -30.00 | -0.5% | ₩6,590.00 | ₩6,680.00 | ₩6,390.00 | 31,884 | |
| ₩6,600.00 | +40.00 | +0.6% | ₩6,750.00 | ₩6,750.00 | ₩6,390.00 | 40,724 | |
| ₩6,560.00 | +160.00 | +2.5% | ₩6,430.00 | ₩6,790.00 | ₩6,350.00 | 65,300 | |
| ₩6,400.00 | 0.00 | 0.0% | ₩6,400.00 | ₩6,650.00 | ₩6,210.00 | 47,674 | |
| ₩6,400.00 | +270.00 | +4.4% | ₩6,270.00 | ₩6,490.00 | ₩6,100.00 | 63,327 | |
| ₩6,130.00 | +50.00 | +0.8% | ₩6,460.00 | ₩6,460.00 | ₩5,950.00 | 38,799 | |
| ₩6,080.00 | -150.00 | -2.4% | ₩6,410.00 | ₩6,460.00 | ₩5,960.00 | 46,639 | |
| ₩6,230.00 | -260.00 | -4.0% | ₩6,400.00 | ₩6,570.00 | ₩6,100.00 | 65,102 | |
| ₩6,490.00 | -180.00 | -2.7% | ₩6,640.00 | ₩6,840.00 | ₩6,370.00 | 63,171 | |
| ₩6,670.00 | -60.00 | -0.9% | ₩6,740.00 | ₩6,870.00 | ₩6,300.00 | 123,020 | |
| ₩6,730.00 | -80.00 | -1.2% | ₩6,810.00 | ₩7,010.00 | ₩6,650.00 | 36,977 | |
| ₩6,810.00 | -200.00 | -2.9% | ₩7,110.00 | ₩7,180.00 | ₩6,730.00 | 63,733 | |
| ₩7,010.00 | -290.00 | -4.0% | ₩7,300.00 | ₩7,470.00 | ₩6,730.00 | 79,755 | |
| ₩7,300.00 | +180.00 | +2.5% | ₩7,060.00 | ₩7,560.00 | ₩6,930.00 | 134,747 | |
| ₩7,120.00 | +390.00 | +5.8% | ₩6,790.00 | ₩7,130.00 | ₩6,730.00 | 86,236 | |
| ₩6,730.00 | -240.00 | -3.4% | ₩6,910.00 | ₩6,920.00 | ₩6,610.00 | 54,923 | |
| ₩6,970.00 | +310.00 | +4.7% | ₩6,840.00 | ₩7,030.00 | ₩6,760.00 | 80,219 |
Splits
1 split · KRX:086820 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split |
- Ticker
- KRX:086820
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW
Bio Solution Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
Valuation
P/E 137× against a median of 1.3×: the highest of 2 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩107.3B KRW
- P/E
- 137×
- EV/sales
- 6.2×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.9×
- Gross margin
- 65.6%
- Operating margin
- −19.4%
- Net margin
- 5.0%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Bio Solution Co., Ltd. · KRX:086820 | US$88.41M | US$79.77M | 137× | 6.2× | n/a | 2.9× | 5.0% | 0.0× | n/a |
| Zura Bio Limited · NASDAQ:ZURA | US$89.63M | −US$98.02M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.52 |
| Infant Bacterial Therapeutics AB Class B · OMXSTO:IBT_B | US$88.54M | US$77.90M | n/a | n/a | n/a | 17.0× | n/a | 0.0× | n/a |
| Y-Biologics Inc. · KRX:338840 | US$87.60M | US$70.95M | n/a | 30.1× | n/a | 6.8× | n/a | 0.9× | n/a |
| Cumberland Pharmaceuticals Inc. · NASDAQ:CPIX | US$87.57M | US$11.59M | 1.3× | 0.5× | n/a | 1.2× | 273.7% | 0.1× | 0.72 |
| Retension Pharmaceuticals, Inc. · NASDAQ:RTSN | US$87.57M | US$78.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Equillium, Inc. · NASDAQ:EQ | US$87.26M | US$34.71M | n/a | n/a | n/a | 1.7× | n/a | 0.0× | 1.31 |
| Upstream Bio, Inc. · NASDAQ:UPB | US$87.15M | −US$119.4M | n/a | −41.6× | n/a | 0.4× | n/a | 0.0× | 1.95 |
| Senhwa Biosciences Inc · TPEX:6492 | US$86.77M | US$67.44M | n/a | 2,117× | n/a | 4.6× | n/a | 0.0× | n/a |
| Bioceltix SA · GPW:BCX | US$86.32M | US$72.38M | n/a | n/a | n/a | 5.6× | n/a | 0.0× | n/a |
| Perspective Therapeutics, Inc. · AMEX:CATX | US$86.05M | −US$114.1M | n/a | −570× | n/a | 0.3× | n/a | 0.0× | 1.47 |
| Median of the others | US$87.41M | US$51.08M | 1.3× | 0.5× | 1.7× | 273.7% | 0.0× | 1.47 |
Forecasts
Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.
- EPS, year to Dec 2026
- -153.00 · 1 analyst
- Revenue, year to Dec 2026
- 20B · 1 analyst
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 15.2B | 12.9B | 12.5B | 10.1B | 11.8B | 7.74B | 8.88B | 10.5B | 5.01B | 3.20B |
| Cost of revenue | 5.61B | 4.73B | 4.40B | 4.17B | 4.19B | 3.44B | 2.98B | 3.51B | 2.47B | 1.90B |
| Gross profit | 9.59B | 8.16B | 8.06B | 5.93B | 7.61B | 4.30B | 5.90B | 7.01B | 2.54B | 1.30B |
| Research and development | 6.31B | 5.75B | 4.39B | 3.84B | 3.66B | 3.23B | 1.99B | 1.77B | 1.45B | |
| Selling, general and administrative | 3.74B | 6.49B | 7.37B | 6.36B | 4.83B | 3.74B | 3.58B | 3.77B | 2.42B | 2.84B |
| Operating income | -4.34B | -10.1B | -5.14B | -5.29B | -1.57B | -3.33B | -1.87B | 1.08B | -1.81B | -3.13B |
| Depreciation and amortization | 2.18B | 1.87B | 2.55B | 2.00B | 1.62B | 1.80B | 1.54B | 487.5M | 489.5M | 427.5M |
| EBITDA | -2.16B | -8.21B | -2.59B | -3.29B | 49.4M | -1.53B | -331.2M | 1.57B | -1.33B | -2.70B |
| Interest expense | 2.81B | 3.13B | 3.26B | 3.07B | 1.09B | 40.5M | 0 | 0 | 0 | 0 |
| Income before tax | 273.4M | -11.9B | -1.36B | -8.09B | -1.68B | -1.80B | -697.5M | 1.35B | -1.81B | -3.09B |
| Net income | 273.4M | -11.9B | -1.36B | -8.09B | -1.68B | -1.80B | -697.5M | 1.35B | -1.81B | -3.09B |
| Earnings per share, basic | 10.59 | -495.55 | -56.35 | -335.97 | -210.90 | -225.77 | -88.12 | 174.40 | -295.66 | -505.54 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 11.9B | 12.9B | 5.49B | 13.4B | 29.0B | 3.39B | 1.51B | 2.77B | 493.1K | 575.0K |
| Short-term investments | 211.7M | 1.43B | 32.2B | 59.4B | 54.1B | 32.8B | 39.0B | 42.1B | 800.0M | 1.91B |
| Receivables | 4.84B | 4.64B | 4.18B | 4.01B | 2.32B | 2.73B | 3.57B | 2.85B | 1.29B | 2.15B |
| Inventory | 1.25B | 1.49B | 1.45B | 1.47B | 1.20B | 1.33B | 529.8M | 693.0M | 616.0M | 549.9M |
| Current assets | 19.4B | 21.0B | 44.2B | 79.2B | 87.1B | 40.7B | 44.8B | 48.5B | 4.30B | 5.34B |
| Property, plant and equipment | 6.45B | 6.91B | 8.45B | 3.95B | 5.23B | 4.11B | 1.82B | 1.94B | 2.29B | |
| Total assets | 68.5B | 67.5B | 92.3B | 91.7B | 94.4B | 49.8B | 51.8B | 52.9B | 7.38B | 8.82B |
| Accounts payable | 255.7M | 458.7M | 278.1M | 173.1M | 149.1M | 195.4M | 98.9M | 226.3M | 257.5M | 253.3M |
| Current liabilities | 34.2B | 33.4B | 47.1B | 45.9B | 48.9B | 2.02B | 2.81B | 1.82B | 1.53B | 1.53B |
| Total debt | 653.0M | 150.5M | ||||||||
| Total liabilities | 36.5B | 36.2B | 50.2B | 48.0B | 49.4B | 3.13B | 3.71B | 3.80B | 2.96B | 2.70B |
| Shareholders' equity | 32.0B | 31.3B | 42.1B | 43.8B | 45.0B | 46.7B | 48.1B | 49.1B | 4.42B | 6.12B |
| Shares outstanding | 25.8M | 24.1M | 24.1M | 24.1M | 7.99M | 7.97M | 7.92M | 7.73M | 6.11M | 6.11M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.31B | -2.29B | 2.16B | -3.81B | 83.3M | -1.69B | -2.61B | 1.03B | -78.5M | -2.07B |
| Capital spending | -731.5M | -1.23B | -1.16B | -4.08B | -663.1M | -1.39B | -2.18B | -707.5M | -187.8M | -1.14B |
| Free cash flow | -2.04B | -3.51B | 1.00B | -7.90B | -579.9M | -4.19B | -4.79B | 318.7M | -266.3M | -3.21B |
| Cash from investing | 24.3B | -9.69B | -12.2B | -17.2B | 3.76B | 795.9M | -43.1B | 874.1M | -27.2M | |
| Cash from financing | -14.7B | -441.6M | 415.7M | 42.6B | -172.0M | 541.7M | 43.4B | 43.4B | 1.40B | |
| Share buybacks | 0 | 350.0M | 169.4M | 508.5M | 1.21B | 43.4B | 1.40B | |||
| Change in cash | -1.04B | 7.44B | -7.96B | -15.5B | 25.6B | 1.88B | -1.26B | 1.30B | 795.3M | -698.1M |
Cap table
Built by 6ix from Bio Solution Co., Ltd.’s releases
- Common shares
- 25,804,277
- Fully diluted
- 25,804,277
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 25,804,277 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 25,804,277 |
Log in to ask 6ix AI your own questions about Bio Solution Co., Ltd.